https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-03-10 / Ther Apher Dial 2022 Jun;26(3):537-547
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-03-10 / Ther Apher Dial 2022 Jun;26(3):537-5472022-03-10 00:00:002022-03-10 00:00:00Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory acute leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-03-08 / Expert Rev Vaccines 2022 Apr;21(4):513-531
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-03-08 / Expert Rev Vaccines 2022 Apr;21(4):513-5312022-03-08 00:00:002022-03-08 00:00:00A comprehensive update to Dendritic Cell therapy for glioma: a systematic review and meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-03-01 / Cancers (Basel) 2022 Mar;14(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-03-01 / Cancers (Basel) 2022 Mar;14(5)2022-03-01 00:00:002022-03-01 00:00:00Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer
